SPHINGO- AND PHOSPHO-LIPIDS METABOLISM IMPAIRMENT AS A POTENTIAL THERAPEUTIC TARGET IN CHARCOT-MARIE-TOOTH TYPE 1A (CMT1A) NEUROPATHY

被引：0
|
作者：
Capodivento, G. [1 ,2 ]
Visigalli, D. [1 ,2 ]
Basit, A. [3 ]
Pastore, V. P. [4 ]
Armirotti, A. [3 ]
Schenone, A. [1 ,2 ]
Nobbio, L. [1 ,2 ]
机构：
[1] Univ Genoa, Dept Neurosci Rehabil Ophthalmol Genet & Maternal, Genoa, Italy
[2] Univ Genoa, CEBR, Genoa, Italy
[3] Ist Italiano Tecnol IIT, Drug Discovery & Dev Dept, Genoa, Italy
[4] Univ Genoa, Dept Informat Bioengn Robot & Syst Engn DIBRIS, Genoa, Italy
来源：
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM | 2015年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S5 / S5
页数：1
相关论文
共 50 条
  • [21] Status of the pivotal phase III study of PXT3003 for Charcot-Marie-Tooth Type 1A disease (CMT1A)
    Goedkoop, Rene
    Attarian, Sharam
    Young, Peter
    Sevilla, Teresa
    Van Damme, Philip
    de Visser, Marianne
    Thomas, Florian
    Roberts, Mark
    Foucquier, Julie
    Boutalbi, Youcef
    Cohen, Daniel
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2018, 23 (04) : 319 - 319
  • [22] A global analysis of the CMT1A locus: implications for the origin and susceptibility to Charcot-Marie-Tooth disease type 1A across populations
    Rodriguez Cruz, P.
    Alitsiou, A.
    Diagne, R.
    Lia-Baldini, A.
    Ghorab, K.
    Diop, A. Gallo
    Ndiaye, M.
    Beltran, S.
    Lao, O.
    NEUROMUSCULAR DISORDERS, 2024, 43
  • [23] LIPID DERANGEMENT IN CHARCOT-MARIE-TOOTH TYPE 1A NEUROPATHY: SEARCHING FOR BIOMARKERS AND THERAPEUTIC TARGETS
    Visigalli, D.
    Capodivento, G.
    Basit, A.
    Armirotti, A.
    Schenone, A.
    Nobbio, L.
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2016, 21 : S35 - S35
  • [24] CHARCOT-MARIE-TOOTH 1A (CMT1A) AND IMPAIRED PATIENT MOBILITY: EXPRESSIONS, REMEDIES AND IMPACT ON QUALITY OF LIFE
    Moore, A.
    Moore, A.
    Aldrich, J.
    VALUE IN HEALTH, 2019, 22 : S346 - S347
  • [25] PRENATAL-DIAGNOSIS OF CHARCOT-MARIE-TOOTH DISEASE TYPE 1A (CMT1A) USING MOLECULAR-GENETIC TECHNIQUES
    NAVON, R
    TIMMERMAN, V
    LOFGREN, A
    LIANG, P
    NELIS, E
    ZEITUNE, M
    Van Broeckhoven, C
    PRENATAL DIAGNOSIS, 1995, 15 (07) : 633 - 640
  • [26] Unmasking a Case of Asymptomatic Charcot-Marie-Tooth Disease (CMT1A) With Vincristine
    Jariwal, Roopam
    Shoua, Basel
    Sabetian, Katayoun
    Natarajan, Piruthiviraj
    Cobos, Everardo
    JOURNAL OF INVESTIGATIVE MEDICINE HIGH IMPACT CASE REPORTS, 2018, 6
  • [27] Therapeutic genome editing for Charcot-Marie-Tooth 1A
    Lee, J. Y.
    Lee, J-S.
    Song, D. W.
    Bae, H. S.
    Yu, H. S.
    Lee, K. J.
    Kim, S.
    Hong, Y. B.
    Choi, B-O.
    Lee, J. M.
    GLIA, 2019, 67 : E462 - E463
  • [28] Utility of Charcot-Marie-Tooth Neuropathy Score in Children With Type 1A Disease
    Haberlova, Jana
    Seeman, Pavel
    PEDIATRIC NEUROLOGY, 2010, 43 (06) : 407 - 410
  • [29] Charcot-Marie-Tooth neuropathy type 1A combined with Duchenne muscular dystrophy
    Vondracek, P.
    Hermanova, M.
    Sedlackova, J.
    Fajkusova, L.
    Stary, D.
    Michenkova, A.
    Gaillyova, R.
    Seeman, P.
    Mazanec, R.
    EUROPEAN JOURNAL OF NEUROLOGY, 2007, 14 (10) : 1182 - 1185
  • [30] ESTIMATION OF THE SIZE OF THE CHROMOSOME 17P11.2 DUPLICATION IN CHARCOT-MARIE-TOOTH NEUROPATHY TYPE-1A (CMT1A)
    RAEYMAEKERS, P
    TIMMERMAN, V
    NELIS, E
    VANHUL, W
    DE JONGHE, P
    MARTIN, JJ
    VANBROECKHOVEN, C
    CEUTERICK, C
    DEWINTER, G
    DENAYER, P
    GHEUENS, J
    JACOBS, K
    MERCELIS, R
    RAES, G
    RINGOET, K
    SMEYERS, G
    SWERTS, L
    VAN DENBERGHE, A
    VANHAERINGEN, A
    VERELLENDUMOULLIN, C
    JOURNAL OF MEDICAL GENETICS, 1992, 29 (01) : 5 - 11
12345